Resources Contact Us Home
Microdose therapy

Image Number 2 for United States Patent #6610652.

Methods for treating vascular conditions associated with localized imbalance in vascular tone, which are hypothesized to be largely due to elevated endothelin (ET) are provided. The methods involve administration of nitric oxide (NO), agents which are able to provide NO, such as NO donors, agents which activate guanyl cyclase, such as YC-1, or agents which prolong the actions of endogenous NO or cyclic guanosine monophosphate (cGMP; a 2nd messenger molecule), such as phosphodiesterase (PDE) inhibitors. According to the invention, such agents are administered in minimal doses or microdoses by any route known in the art, so as to provide dosages which are about one half to about one twentieth (1/2 to 1/20) of those known to induce vasodilation in "normal" circulations. The low doses of these agents effectively alleviate vascular conditions associated with a reduction in NO production or an attenuation of NO effect, by restoring balance in vascular tone while exerting almost no systemic effect in normal vasculature.

  Recently Added Patents
Maize variety inbred PH1CD7
Dynamically reconfigurable systolic array accelorators
Rechargeable battery including a channel member
Method of fabricating solid electrolytic capacitor and solid electrolytic capacitor
Multilayer films having reduced curling
Method for manufacturing semiconductor device
  Randomly Featured Patents
Aging of aluminum alloys for improved combination of fatigue performance and strength
Television receiver
Form and seal unit for a machine for packaging pourable food products
Preparation of alcohols from synthesis gas
Pool table
Switching device of a two-stage planetary gear
Cyanine compound having a hetero ring containing an imidazole nucleus fused to a naphthoquinone nucleus
Sewing machine
Shoe sole
Medical electrocautery instrument assistant device